Invention Grant
US07674769B2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
失效
通过给予组织因子途径抑制剂（TFPI）治疗重症肺炎
- Patent Title: Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
- Patent Title (中): 通过给予组织因子途径抑制剂（TFPI）治疗重症肺炎
-
Application No.: US10270478Application Date: 2002-10-15
-
Publication No.: US07674769B2Publication Date: 2010-03-09
- Inventor: Abla Creasey
- Applicant: Abla Creasey
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agency: Banner & Witcoff, Ltd.
- Main IPC: A61K38/57
- IPC: A61K38/57 ; C07K14/81
Abstract:
Methods for prophylactically or therapeutically treating severe pneumonia involve administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from or at risk of developing this condition. The methods involve the use of continuous intravenous infusion of TFPI or a TFPI analog, preferably at low doses to avoid adverse side effects.
Public/Granted literature
- US20030139339A1 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) Public/Granted day:2003-07-24
Information query
IPC分类:
